Clinical trial
Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born…
NCT00174408 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00174408 |
|---|---|
| Title | Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age |
| Official title | Growth Hormone Treatment in Short Children Born Small for Date (Genotonorm) |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Growth Disorders |
| Intervention type | Drug |
| Interventions | Genotropin |
| Enrollment | 110 |
| Start date | Mar 1, 1990 |
| Completion | Feb 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | May 3, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: